research

Today we’re going through a new method for identifying variants of concern using Sanger sequencing, and we’re joined by two of the authors of this method Kai Blin and Tue Jorgensen, both from the Technical University of Denmark. 

The preprint: 
https://www.medrxiv.org/content/10.1101/2021.03.27.21252266v1

The protocol: 
https://www.protocols.io/view/sanger-sequencing-of-a-part-of-the-sars-cov-2-spik-bsbdnai6

The software: 
https://github.com/kblin/covid-spike-classification

The web app: 
https://ssi.biolib.com/app/covid-spike-classification/run

55 SARS-CoV-2 And Sequencing Spike With Sanger Sequencing - Welcome To 1995

Want to learn more about the microbiome? In the first episode of three on the microbiome, the focus topic for the September 2016 issue of the Yale Journal of Biology and Medicine, we will be discussing the history of the field, current techniques used in microbiome research, and how the microbiome influences our health.

Yale University

Microbiome: Episode I

What has the microbiome taught us? In the second episode on the microbiome, we are joined by Yale rheumatologist and assistant professor of Immunobiology and Medicine, Dr. Martin Kriegel to discuss articles published in our issue, current research on the microbiome, how the microbiome is being applied in the clinic, and where the future of microbiome research lie

Microbiome: Episode II

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. The guideline discussed in this podcast is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association, European Digestive Surgery, and the European Society of Gastrointestinal Endoscopy.
Listen to the discussion between the Education Editor of Gut, Mairi McLean, and Marco del Chiaro, from The European Study Group on Cystic Tumours of the Pancreas. And read the details of the guidelines on the Gut website: https://gut.bmj.com/content/67/5/789.

European evidence-based guidelines on pancreatic cystic neoplasms

Today’s special edition features an extended conversation between Dr. Eric Topol, Director of the Scripps Research Translational Institute, and Professor Dennis Burton, Chair of the Department of Immunology and Microbiology at Scripps Research. Listen as they talk about antibody cocktail treatments, the mystery of “longhaul” COVID-19 symptoms and how close we are to developing a coronavirus vaccine.

Transcript of today's episode
https://www.scripps.edu/covid-19/videos/topol-burton/index.html

Dr. Eric Topol’s bio
https://www.scripps.edu/faculty/topol/

Prof. Dennis Burton’s bio
https://www.scripps.edu/faculty/burton/

Efficacy of convalescent plasma
https://www.sandiegouniontribune.com/business/biotech/story/2020-08-30/hundreds-of-san-diegans-with-covid-19-have-already-been-treated-with-plasma-but-does-it-work

“COVID longhaulers”
https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/

Coronavirus vaccine Q&A with Prof. Dennis Burton
https://www.sandiegouniontribune.com/business/biotech/story/2020-07-26/q-a-an-update-on-the-race-for-a-covid-19-vaccine-scripps-research-immunologist-dennis-burton 

Dr. Eric Topol on social media:
Twitter: @EricTopol
Instagram: @erictopol1

Scripps Research on social media:
Twitter, Instagram: @scrippsresearch
Facebook: @ScrippsResearchInstitute 
LinkedIn: the-scripps-research-institute

research

Hassan Mohammad 9